0

541096

BPLPHARMA

img img img img
No Data Available

Bharat Parenterals Limited Share Price Update

As of the latest trading session, Bharat Parenterals Limited share price is currently at ₹1045, which is up by ₹18.69 from its previous closing. Today, the stock has fluctuated between ₹1010.05 and ₹1045.00. Over the past year, Bharat Parenterals Limited has achieved a return of -8.42%. In the last month alone, the return has been -11.37%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Bharat Parenterals Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    719.80

  • P/E Ratio (TTM)

    42.54

  • Beta

    0.61

  • Book Value / share

    578.77

  • Return on equity

    8.81%

  • EPS (TTM)

    24.55

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    1.92

info icon alternate text

Bharat Parenterals Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 41.41
Operating Expense 40.58
Net Profit 1.92
Net Profit Margin (%) 4.63
Earnings Per Share (EPS) 2.78
EBITDA 5.75
Effective Tax Rate (%) 38.06
Particulars SEP 2025 (Values in Cr)
Revenue 41.70
Operating Expense 42.49
Net Profit 2.73
Net Profit Margin (%) 6.54
Earnings Per Share (EPS) 3.96
EBITDA 6.55
Effective Tax Rate (%) 20.17
Particulars JUN 2025 (Values in Cr)
Revenue 94.37
Operating Expense 82.59
Net Profit 10.00
Net Profit Margin (%) 10.59
Earnings Per Share (EPS) 14.51
EBITDA 16.88
Effective Tax Rate (%) 25.37
Particulars MAR 2025 (Values in Cr)
Revenue 80.28
Operating Expense 79.00
Net Profit 2.28
Net Profit Margin (%) 2.84
Earnings Per Share (EPS) 3.48
EBITDA 6.84
Effective Tax Rate (%) 35.59
Particulars DEC 2024 (Values in Cr)
Revenue 67.34
Operating Expense 62.26
Net Profit 6.50
Net Profit Margin (%) 9.65
Earnings Per Share (EPS) 8.30
EBITDA 12.13
Effective Tax Rate (%) 26.71
Particulars MAR 2025 (Values in Cr)
Revenue 304.13
Operating Expense 282.37
Net Profit 26.45
Net Profit Margin (%) 8.69
Earnings Per Share (EPS) 40.36
EBITDA 48.16
Effective Tax Rate (%) 27.14
Particulars MAR 2024 (Values in Cr)
Revenue 257.98
Operating Expense 235.22
Net Profit 22.59
Net Profit Margin (%) 8.75
Earnings Per Share (EPS) 38.97
EBITDA 41.00
Effective Tax Rate (%) 26.65
Particulars MAR 2023 (Values in Cr)
Revenue 217.98
Operating Expense 204.65
Net Profit 24.34
Net Profit Margin (%) 11.16
Earnings Per Share (EPS) 42.40
EBITDA 40.21
Effective Tax Rate (%) 24.33
Particulars MAR 2022 (Values in Cr)
Revenue 212.01
Operating Expense 191.42
Net Profit 21.30
Net Profit Margin (%) 10.04
Earnings Per Share (EPS) 37.11
EBITDA 36.00
Effective Tax Rate (%) 24.92
Particulars MAR 2021 (Values in Cr)
Revenue 203.67
Operating Expense 185.32
Net Profit 20.21
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 35.27
EBITDA 33.44
Effective Tax Rate (%) 25.20
Particulars MAR 2025 (Values in Cr)
Book Value / Share 479.79
ROE % -16.55
ROCE % -4.76
Total Debt to Total Equity 0.64
EBITDA Margin 4.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 338.96
ROE % 5.53
ROCE % 7.71
Total Debt to Total Equity 0.55
EBITDA Margin 12.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 316.55
ROE % 9.01
ROCE % 12.50
Total Debt to Total Equity 0.19
EBITDA Margin 14.69
Particulars MAR 2022 (Values in Cr)
Book Value / Share 287.16
ROE % 13.44
ROCE % 17.10
Total Debt to Total Equity 0.10
EBITDA Margin 16.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.09
ROE % 15.51
ROCE % 20.16
Total Debt to Total Equity 0.05
EBITDA Margin 16.58
Particulars MAR 2025 (Values in Cr)
Book Value / Share 561.27
ROE % 8.81
ROCE % 10.88
Total Debt to Total Equity 0.24
EBITDA Margin 15.84
Particulars MAR 2024 (Values in Cr)
Book Value / Share 367.05
ROE % 11.16
ROCE % 12.94
Total Debt to Total Equity 0.32
EBITDA Margin 14.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 330.86
ROE % 11.08
ROCE % 13.60
Total Debt to Total Equity 0.17
EBITDA Margin 13.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 287.72
ROE % 13.74
ROCE % 17.51
Total Debt to Total Equity 0.09
EBITDA Margin 15.08
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.22
ROE % 15.13
ROCE % 19.72
Total Debt to Total Equity 0.05
EBITDA Margin 16.60
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 12.09
Total Assets 503.82
Total Liabilities 503.82
Total Equity 238.17
Share Outstanding 0
Price to Book Ratio 3.06
Return on Assets (%) 2.88
Return on Capital (%) 3.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 350.34
Total Liabilities 350.34
Total Equity 217.89
Share Outstanding 0
Price to Book Ratio 1.02
Return on Assets (%) 4.69
Return on Capital (%) 6.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.00
Total Liabilities 0.00
Total Equity 0.00
Share Outstanding 0
Price to Book Ratio 1.19
Return on Assets (%) 0.00
Return on Capital (%) 0
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 198.64
Total Liabilities 198.64
Total Equity 143.81
Share Outstanding 0
Price to Book Ratio 1.33
Return on Assets (%) 10.26
Return on Capital (%) 13.07
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.40
Total Assets 187.49
Total Liabilities 187.49
Total Equity 118.18
Share Outstanding 0
Price to Book Ratio 0.66
Return on Assets (%) 12.87
Return on Capital (%) 20.31
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 27.77
Total Assets 549.19
Total Liabilities 549.19
Total Equity 386.82
Share Outstanding 0
Price to Book Ratio 1.76
Return on Assets (%) 4.81
Return on Capital (%) 5.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.09
Total Assets 387.15
Total Liabilities 387.15
Total Equity 213.60
Share Outstanding 0
Price to Book Ratio 3.06
Return on Assets (%) 5.83
Return on Capital (%) 7.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.42
Total Assets 308.02
Total Liabilities 308.02
Total Equity 191.06
Share Outstanding 0
Price to Book Ratio 1.02
Return on Assets (%) 7.90
Return on Capital (%) 10.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.60
Total Assets 218.00
Total Liabilities 218.00
Total Equity 166.15
Share Outstanding 0
Price to Book Ratio 1.19
Return on Assets (%) 9.77
Return on Capital (%) 11.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.15
Total Assets 196.23
Total Liabilities 196.23
Total Equity 143.94
Share Outstanding 0
Price to Book Ratio 1.33
Return on Assets (%) 10.29
Return on Capital (%) 13.15
Particulars MAR 2025 (Values in Cr)
Net Income -33.95
Cash from Operations -16.65
Cash from Investing -137.38
Cash from Financing 156.37
Net change in Cash -8.26
Free Cash Flow 12.41
Particulars MAR 2024 (Values in Cr)
Net Income 18.72
Cash from Operations 4.75
Cash from Investing -104.78
Cash from Financing 110.42
Net change in Cash 0.93
Free Cash Flow 109.05
Particulars MAR 2023 (Values in Cr)
Net Income 23.54
Cash from Operations 30.45
Cash from Investing -77.81
Cash from Financing 60.59
Net change in Cash 4.44
Free Cash Flow 122.05
Particulars MAR 2022 (Values in Cr)
Net Income 27.87
Cash from Operations 4.60
Cash from Investing -6.63
Cash from Financing 9.42
Net change in Cash 1.72
Free Cash Flow 43.55
Particulars MAR 2021 (Values in Cr)
Net Income 27.12
Cash from Operations 31.12
Cash from Investing -43.37
Cash from Financing 10.49
Net change in Cash -8.42
Free Cash Flow 31.96
Particulars MAR 2025 (Values in Cr)
Net Income 36.31
Cash from Operations 29.29
Cash from Investing -89.68
Cash from Financing 69.25
Net change in Cash -1.21
Free Cash Flow 49.61
Particulars MAR 2024 (Values in Cr)
Net Income 30.80
Cash from Operations 9.30
Cash from Investing -38.19
Cash from Financing 33.51
Net change in Cash -4.84
Free Cash Flow 19.67
Particulars MAR 2023 (Values in Cr)
Net Income 32.16
Cash from Operations -2.77
Cash from Investing -13.94
Cash from Financing 28.52
Net change in Cash 3.01
Free Cash Flow 2.28
Particulars MAR 2022 (Values in Cr)
Net Income 28.36
Cash from Operations -16.40
Cash from Investing 21.75
Cash from Financing 2.24
Net change in Cash 1.92
Free Cash Flow -11.64
Particulars MAR 2021 (Values in Cr)
Net Income 27.01
Cash from Operations 36.35
Cash from Investing -46.27
Cash from Financing 8.31
Net change in Cash -8.28
Free Cash Flow 41.77
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 12.37 1.48 219.02 23.12 / 52.00
BLISS GVS PHARMA LTD 217.80 20.82 2.03 2304.08 105.05 / 225.00
CIPLA LTD 1330.85 22.61 3.26 107503.49 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 310.90 10.34 2.34 915.01 219.00 / 399.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 23.24 3.98 219.02 23.12 / 52.00
AMRUTAJAN HEALTH LTD 632.15 31.61 5.34 1827.59 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8878.75 106.70 27.78 22196.88 6501.60 / 10653.05
BLISS GVS PHARMA LTD 217.80 29.67 2.08 2304.08 105.05 / 225.00

Bharat Parenterals Limited shareholding pattern

Holding

32.15%
67.19%
0.1%
0.54%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Bharat Parenterals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1044.40 1.76 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 1028.60
  • 26 Days 1053.30
  • 10 Days 1019.30
  • 50 Days 1096.80
  • 12 Days 1021.00
  • 100 Days 1153.00
  • 20 Days 1038.90
  • 200 Days 1205.70
1033.08 PIVOT

First Support

1018.27

First Resistance

1041.12

Second Support

1010.23

Second Resistance

1055.93

Third Support

995.42

Third Resistance

1063.97

RSI

48.30

ADX

27.52

MACD

-32.27

Williams % R

-45.14

Commodity Channel Index (CCI)

0.56

Date

2026-02-13

Week

667.00

Same Day

369.00

Month

2385.00

1 Year

0.62

3 Year

0.55

Over 1 Month

-11.37%

down

Over 1 Year

-8.42%

down

Over 3 Months

-7.14%

down

Over 3 Years

46.44%

down

Over 6 Months

-26.15%

down

Over 5 Years

24.55%

down

Bharat Parenterals Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2025 1.0 Final 19 Sep 2025 Equity shares
25 Jun 2024 1.0 Final 25 Jun 2024 Equity shares
25 Sep 2023 0.75 Final 25 Sep 2023 Equity shares

Top Gainers

Bharat Parenterals Limited Share Price

Bharat Parenterals Limited was incorporated in September, 1992 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics.

In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company on 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective from 28th June, 2022.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bharat Parenterals Ltd?

Answer Field

Bharat Parenterals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1,044.40 as on Feb 13 2026 03:28 PM.

What is the Market Cap of Bharat Parenterals Ltd Share?

Answer Field

The market cap of Bharat Parenterals Ltd for NSE ₹ 0.00 & for BSE ₹ 719.80 as on Feb 13 2026 03:28 PM.

What is the 52 Week High and Low of Bharat Parenterals Ltd?

Answer Field

The 52 Week High and Low of Bharat Parenterals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1,667.20 and ₹ 802.00.

What is 1 year return for Bharat Parenterals Ltd?

Answer Field

The 1 year returns on the stock has been -8.42%.

What is the P/E Ratio of Bharat Parenterals Ltd Share?

Answer Field

As on Feb 13 2026 03:28 PM the price-to-earnings (PE) ratio for Bharat Parenterals Ltd share is 42.54.

What is the PB ratio of Bharat Parenterals Ltd Share?

Answer Field

As on Feb 13 2026 03:28 PM, the price-to-book (PB) ratio for Bharat Parenterals Ltd share is 578.77.

How to Buy Bharat Parenterals Ltd Share?

Answer Field

You can trade in Bharat Parenterals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bharat Parenterals Ltd Share on Bajaj Broking App?

Answer Field

To buy Bharat Parenterals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bharat Parenterals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59